Envestnet Asset Management Inc. Sells 66,651 Shares of Azenta, Inc. (NASDAQ:AZTA)

Envestnet Asset Management Inc. lessened its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 11.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 513,484 shares of the company’s stock after selling 66,651 shares during the quarter. Envestnet Asset Management Inc. owned about 0.95% of Azenta worth $27,020,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Hantz Financial Services Inc. bought a new stake in shares of Azenta in the second quarter worth about $30,000. Principal Securities Inc. bought a new stake in Azenta in the 4th quarter worth approximately $36,000. Benjamin F. Edwards & Company Inc. purchased a new stake in shares of Azenta during the 1st quarter worth approximately $38,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Azenta during the 1st quarter valued at approximately $49,000. Finally, Lazard Asset Management LLC purchased a new position in shares of Azenta in the first quarter valued at $130,000. 99.08% of the stock is owned by hedge funds and other institutional investors.

Azenta Stock Down 0.5 %

AZTA opened at $49.27 on Friday. The company has a market cap of $2.66 billion, a P/E ratio of -18.18 and a beta of 1.47. The firm’s 50-day moving average price is $52.36 and its 200-day moving average price is $53.93. Azenta, Inc. has a 52-week low of $44.00 and a 52-week high of $69.16.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, August 6th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.09. Azenta had a positive return on equity of 0.89% and a negative net margin of 23.66%. The firm had revenue of $173.00 million during the quarter, compared to the consensus estimate of $166.14 million. During the same quarter in the previous year, the company posted $0.13 earnings per share. The company’s revenue was up 4.2% compared to the same quarter last year. On average, research analysts anticipate that Azenta, Inc. will post 0.33 EPS for the current fiscal year.

Analysts Set New Price Targets

AZTA has been the subject of several research reports. Needham & Company LLC reiterated a “buy” rating and set a $69.00 price objective on shares of Azenta in a research report on Wednesday, August 7th. Evercore ISI increased their price target on shares of Azenta from $52.00 to $53.00 and gave the company an “in-line” rating in a report on Tuesday, July 2nd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Azenta currently has an average rating of “Hold” and an average price target of $67.00.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.